Burjeel Holdings Awarded “Most Honored Company” in Institutional Investor’s 2024 Emerging EMEA Executive Team Survey
Stay Updated with the Latest Developments at Burjeel Medical City
Burjeel Holdings Awarded “Most Honored Company” in Institutional Investor’s 2024 Emerging EMEA Executive Team Survey
Abu Dhabi, United Arab Emirates, 6 September 2024: Burjeel Holdings PLC (“Burjeel” or “the Group”), a leading super-specialty healthcare services provider in the MENA region, which is listed on the Abu Dhabi Securities Exchange, was recognized as a “Most Honored Company” in its debut appearance in the 2024 Emerging EMEA Executive Team Survey by Institutional Investor Research.
The Group was highlighted for its strength in investor relations, and was one of only six companies in the UAE to receive the “Most Honored Company” distinction. Burjeel came in second place in seven categories within the Emerging EMEA “Health Care & Pharmaceuticals” segment of the 2024 survey, which is based on rankings from the buy-side and sell-side investment community:
- Best CEO — John Sunil
- Best CFO — Muhammad Shihabuddin
- Best IR Professional — Sergei Levitskii
- Best ESG Program
- Best Investor/ Analyst Day
- Best IR Program
- Best IR Team
This year, the Emerging EMEA Executive Team Survey reflects the votes and opinions of 405 investment professionals at 248 financial services firms. Only 33 out of 332 companies from 11 sectors across the Emerging EMEA region received the “Most Honored Company” distinction.
The Group’s achievements are testament to its outstanding performance, recognized by investors and the market, and reflect the growth in its foreign investor base. Ranking as a top company in IR in the Emerging EMEA region highlights Burjeel’s commitment to providing quality disclosures, timely responses to investor queries, and effective investor communication.
We are proud and honored to be recognized by Institutional Investor Research for our performance. These achievements reflect the confidence of investors and analysts in Burjeel Holdings, highlighting the company’s excellence in financial disclosure, risk management, and commitment to transparent timely communication with external stakeholders. We will continue to further consolidate our leading position in the UAE healthcare market, maximize our shareholder value, and reinforce our daily commitment to the community.
Mr. Muhammed Shihabuddin
Group Chief Financial Officer
About Institutional Investor Research
Institutional Investor Research (IIR) is a renowned provider of independent data-driven insights and actionable feedback for the sell side, corporates, and buy side. They conduct comprehensive research surveys with global investment professionals to evaluate and rank the best-performing investment professionals, service providers, asset managers, and corporate executives.
About Burjeel Holdings
Founded in 2007, Burjeel Holdings is a leading super-specialty healthcare services provider in the UAE and Oman, and it operates a growing specialized healthcare segment in Saudi Arabia. The Group developed an integrated and multi-brand healthcare ecosystem across primary, secondary, tertiary, and quaternary medical care, ensuring complex care delivery to
Our network comprises 89 assets across the UAE, Oman, and Saudi Arabia, including 19 hospitals, 47 medical centers, 15 pharmacies, and other allied services. Burjeel Holdings’ brands include Burjeel, Medeor, LLH, Lifecare, PhysioTherabia and Tajmeel.
Burjeel Medical City Launches Sarcoma & Bone Center to Strengthen Care for Rare and Complex Cancers
New multidisciplinary center at Burjeel Cancer Institute integrates oncology, orthopedic surgery, and
Left Hand in the Right Hands: Abu Dhabi Doctors Save Man’s Arm After Complete Amputation Through a 10-Hour Complex Microsurgery
Specialists at Burjeel Medical City replanted the patient’s arm that was caught in a
Burjeel Eye Institute Launched at Burjeel Medical City to Enhance Specialized Eye Care in Abu Dhabi
A part of Burjeel Medical City’s integrated healthcare ecosystem, the institute offers precise, personalized, and
Burjeel’s 8,500-strong Town Hall Marks First-of-its-kind Leadership Address in the UAE, with AED 15 Million Surprise for Frontline Workers
Chairman and CEO Dr. Shamsheer Vayalil announces major frontliner recognition fund during
Burjeel Holdings Achieves NIHS Accreditation for the First Adult Critical Care Nursing Residency Program in the UAE and Region
The recognition positions the Group as a national and regional leader in advanced nursing
Burjeel Cancer Institute’s Breast Cancer Clinical Care Program Earns JCI Gold Certification
BCI achieved a flawless result with no findings or non-conformities, marking an
Burjeel Holdings Secures Two Wins at Emirates Labour Market Award
The Group won awards in the ‘Establishments’ and ‘Outstanding Workforce’ categories, reaffirming its commitment to developing a dynamic
Global Experts Unite in Abu Dhabi to Shape the Future of Pediatric Bone Marrow Transplantation and Gene Therapy
Over 700 specialists gather at the Fourth Emirates Pediatric BMT and Gene Therapy